Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Guloksuz, S; Pries, LK; Delespaul, P; Kenis, G; Luykx, JJ; Lin, BCD; Richards, AL; Akdede, B; Binbay, T; Altinyazar, V; Yalincetin, B; Gumus-Akay, G; Cihan, B; Soygur, H; Ulas, H; Cankurtaran, ES; Kaymak, SU; Mihaljevic, MM; Petrovic, SA; Mirjanic, T; Bernardo, M; Cabrera, B; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Sanjuan, J; Aguilar, EJ; Santos, JL; Jimenez-Lopez, E; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Maric, NP; Atbasoglu, C; Ucok, A; Alptekin, K; Saka, MC; Arango, C; O'Donovan, M; Rutten, BPF; van Os, J; Alizadeh, BZ; van Amelsvoort, T; van Beveren, NJ; Bruggeman, R; Cahn, W; de Haan, L; Myin-Germeys, I; van Winkel, R; Genetic Risk Outcome Psychosis.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

World Psychiatry. 2019; 18(2): 173-182 Nº de citas: 150 [doi:10.1002/wps.20629]

Quattrone D; Di Forti M; Gayer-Anderson C; Ferraro L; Jongsma HE; Tripoli G; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szoke A; Arango C; Lasalvia A; Tortelli A; Llorca PM; de Haan L; Velthorst E; Bobes J; Bernardo M; Sanjuan J; Santos JL; Arrojo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Richards AL; O'Donovan MC; Sham PC; Vassos E; Rutten BP; van Os J; Morgan C; Lewis CM; Murray RM; Reininghaus U; EU-GEI WP2 Group.

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

PSYCHOLOGICAL MEDICINE. 2019; 49(8): 1378-1391 Nº de citas: 84 [doi:10.1017/S0033291718002131]

van den Heuvel, MP; Scholtens, LH; van der Burgh, HK; Agosta, F; Alloza, C; Arango, C; Auyeung, B; Baron-Cohen, S; Basaia, S; Benders, MJNL; Beyer, F; Booij, L; Braun, KPJ; Busatto, G; Cahn, W; Cannon, DM; Chaim-Avancini, TM; Chan, SSM; Chen, EYH; Crespo-Facorro, B; Crone, EA; Dannlowski, U; de Zwarte, SMC; Dietsche, B; Donohoe, G; Du Plessis, S; Durston, S; Diaz-Caneja, CM; Diaz-Zuluaga, AM; Emsley, R; Filippi, M; Frodl, T; Gorges, M; Graff, B; Grotegerd, D; Gasecki, D; Hall, JM; Holleran, L; Holt, R; Hopman, HJ; Jansen, A; Janssen, J; Jodzio, K; Jancke, L; Kaleda, VG; Kassubek, J; Masouleh, SK; Kircher, T; Koevoets, MGJC; Kostic, VS; Krug, A; Lawrie, SM; Lebedeva, IS; Lee, EHM; Lett, TA; Lewis, SJG; Liem, F; Lombardo, MV; Lopez-Jaramillo, C; Margulies, DS; Markett, S; Marques, P; Martinez-Zalacain, I; McDonald, C; McIntosh, AM; McPhilemy, G; Meinert, SL; Menchon, JM; Montag, C; Moreira, PS; Morgado, P; Mothersill, DO; Merillat, S; Muller, HP; Nabulsi, L; Najt, P; Narkiewicz, K; Naumczyk, P; Oranje, B; de la Foz, VOG; Peper, JS; Pineda, JA; Rasser, PE; Redlich, R; Repple, J; Reuter, M; Rosa, PGP; Ruigrok, ANV; Sabisz, A; Schell, U; Seedat, S; Serpa, MH; Skouras, S; Soriano-Mas, C; Sousa, N; Szurowska, E; Tomyshev, AS; Tordesillas-Gutierrez, D; Valk, SL; van den Berg, LH; van Erp, TGM; van Haren, NEM; van Leeuwen, JMC; Villringer, A; Vinkers, CCH; Vollmar, C; Waller, L; Walter, H; Whalley, HC; Witkowska, M; Witte, AV; Zanetti, MV; Zhang, R; de Lange, SC; Cambridge Child Dev Project.

10Kin1day: A Bottom-Up Neuroimaging Initiative

Frontiers in Neurology. 2019; 10: Nº de citas: 16 [doi:10.3389/fneur.2019.00425]

Di Forti, M; Quattrone, D; Freeman, TP; Tripoli, G; Gayer-Anderson, C; Quigley, H; Rodriguez, V; Jongsma, HE; Ferraro, L; La Cascia, C; La Barbera, D; Tarricone, I; Berardi, D; Szoke, A; Arango, C; Tortelli, A; Velthorst, E; Bernardo, M; Del-Ben, CM; Menezes, PR; Selten, JP; Jones, PB; Kirkbride, JB; Rutten, BPF; de Haan, L; Sham, PC; van Os, J; Lewis, CM; Lynskey, M; Morgan, C; Murray, RM; EU-GEI WP2 Grp.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Lancet Psychiatry. 2019; 6(5): 427-436 Nº de citas: 641 [doi:10.1016/S2215-0366(19)30048-3]

Penzol, MJ; de Pablo, GS; Llorente, C; Moreno, C; Hernandez, P; Dorado, ML; Parellada, M.

Functional Gastrointestinal Disease in Autism Spectrum Disorder: A Retrospective Descriptive Study in a Clinical Sample

Frontiers in Psychiatry. 2019; 10: Nº de citas: 47 [doi:10.3389/fpsyt.2019.00179]

Fores-Martos, J; Catala-Lopez, F; Sanchez-Valle, J; Ibanez, K; Tejero, H; Palma-Gudiel, H; Climent, J; Pancaldi, V; Fananas, L; Arango, C; Parellada, M; Baudot, A; Vogt, D; Rubenstein, JL; Valencia, A; Tabares-Seisdedos, R.

Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

Molecular Autism. 2019; 10: Nº de citas: 39 [doi:10.1186/s13229-019-0262-8]

Diaz-Caneja, CM; Schnack, H; Martinez, K; Santonja, J; Aleman-Gomez, Y; Pina-Camacho, L; Moreno, C; Fraguas, D; Arango, C; Parellada, M; Janssen, J.

Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders

HUMAN BRAIN MAPPING. 2019; 40(5): 1643-1653 Nº de citas: 9 [doi:10.1002/hbm.24475]

Arango, C; Baeza, I; Bernardo, M; Canas, F; de Dios, C; Diaz-Marsa, M; Garcia-Portilla, MP; Gutierrez-Rojas, L; Olivares, JM; Rico-Villademoros, F; Rodriguez-Jimenez, R; Sanchez-Morla, EM; Segarra, R; Crespo-Facorro, B.

Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

Spanish Journal of Psychiatry and Mental Health. 2019; 12(2): 92-105 Nº de citas: 36 [doi:10.1016/j.rpsm.2018.03.006]

Howard, DM; Adams, MJ; Clarke, TK; Hafferty, JD; Gibson, J; Shirali, M; Coleman, JRI; Hagenaars, SP; Ward, J; Wigmore, EM; Alloza, C; Shen, X; Barbu, MC; Xu, EY; Whalley, HC; Marioni, RE; Porteous, DJ; Davies, G; Deary, IJ; Hemani, G; Berger, K; Teismann, H; Rawal, R; Arolt, V; Baune, BT; Dannlowski, U; Domschke, K; Tian, C; Hinds, DA; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Hicks, B; Huber, KE; Jewett, EM; Jiang, Y; Kleinman, A; Lin, KH; Litterman, NK; McIntyre, MH; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Poznik, GD; Sathirapongsasuti, JF; Sazonova, OV; Shelton, JF; Shringarpure, S; Tung, JY; Vacic, V; Wang, X; Wilson, CH; Trzaskowski, M; Byrne, EM; Ripke, S; Smith, DJ; Sullivan, PF; Wray, NR; Breen, G; Lewis, CM; McIntosh, AM; 23andMe Res Team; Major Depressive Disorder Working.

Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

NATURE NEUROSCIENCE. 2019; 22(3): 343 Nº de citas: 1817 [doi:10.1038/s41593-018-0326-7]

Barbeito, S; Sanchez-Gutierrez, T; Mayoral, M; Moreno, M; Rios-Aguilar, S; Arango, C; Calvo, A.

Mobile App-Based Intervention for Adolescents With First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled Trial

Frontiers in Psychiatry. 2019; 10: Nº de citas: 12 [doi:10.3389/fpsyt.2019.00027]

van der Wee NJA; Bilderbeck, AC; Cabello, M; Ayuso-Mateos, JL; Saris IMJ; Giltay, EJ; Penninx, BWJH; Arango, C; Post, A; Porcelli, S.

Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 38-46 Nº de citas: 23 [doi:10.1016/j.neubiorev.2018.06.020]

Kas, MJ; Penninx, B; Sommer, B; Serretti, A; Arango, C; Marston, H.

A quantitative approach to neuropsychiatry: The why and the how

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 3-9 Nº de citas: 87 [doi:10.1016/j.neubiorev.2017.12.008]

Bilderbeck, AC; Penninx BWJH; Arango, C; van der Wee, N; Kahn, R; Winter-van Rossum, I; Hayen, A; Kas, MJ; Post, A; Dawson, GR.

Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 87-93 Nº de citas: 27 [doi:10.1016/j.neubiorev.2018.06.019]

Gialloreti, LE; Mazzone, L; Benvenuto, A; Fasano, A; Alcon, AG; Kraneveld, A; Moavero, R; Raz, R; Riccio, MP; Siracusano, M; Zachor, DA; Marini, M; Curatolo, P.

Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations

Journal of Clinical Medicine. 2019; 8(2): Nº de citas: 107 [doi:10.3390/jcm8020217]

Martinuzzi, E; Barbosa, S; Daoudlarian, D; Ali, WBH; Gilet, C; Fillatre, L; Khalfallah, O; Troudet, R; Jamain, S; Fond, G; Sommer, I; Leucht, S; Dazzan, P; McGuire, P; Arango, C; Diaz-Caneja, CM; Fleischhacker, W; Rujescu, D; Glenthoj, B; Winter, I; Kahn, RS; Yolken, R; Lewis, S; Drake, R; Davidovic, L; Leboyer, M; Glaichenhaus, N; Kahn, RS; van Rossum, IW; Leucht, S; McGuire, P; Lewis, SW; Leboyer, M; Arango, C; Dazzan, P; Drake, R; Heres, S; Diaz-Caneja, CM; Rujescu, D; Weiser, M; Galderisi, S; Glenthoj, B; Eijkemans, MJC; Fleischhacker, WW; Kapur, S; Sommer, IE; OPTiMiSE Study Grp.

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

Translational Psychiatry. 2019; 9: Nº de citas: 60 [doi:10.1038/s41398-018-0366-5]

Jaen-Moreno, MJ; Feu, N; Redondo-Ecija, J; Montiel, FJ; Gomez, C; del Pozo, GI; Alcala, JA; Gutierrez-Rojas, L; Balanza-Martinez, V; Chauca, GM; Carrion, L; Osuna, MI; Sanchez, MD; Caro, I; Ayora, M; Valdivia, F; Lopez, MS; Poyato, JM; Sarramea, F.

Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk TIMER): study protocol for a randomized controlled trial

Trials. 2019; 20: Nº de citas: 5 [doi:10.1186/s13063-018-3139-9]

Downs, J; Dean, H; Lechler, S; Sears, N; Patel, R; Shetty, H; Hotopf, M; Ford, T; Kyriakopoulos, M; Diaz-Caneja, CM; Arango, C; MacCabe, JH; Hayes, RD; Pina-Camacho, L.

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure

SCHIZOPHRENIA BULLETIN. 2019; 45(1): 69-79 Nº de citas: 44 [doi:10.1093/schbul/sbx197]

Fraguas, D; Diaz-Caneja, CM; Pina-Camacho, L; Umbricht, D; Arango, C.

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis

SCHIZOPHRENIA BULLETIN. 2019; 45(1): 57-68 Nº de citas: 26 [doi:10.1093/schbul/sbx192]